News RSS
Press Releases:
July 14, 2008, San Jose, California "Edison Pharma Hits Milestone as A0001 Enters Phase 1 Clinical Development"
July 07, 2008, San Jose, California "Edison Pharmaceuticals Receives Commendation From the City of San Jose"
August 02, 2007, San Jose, California "Edison Pharmaceuticals Closes Series B Financing"
July 17, 2007, Danbury, Connecticut "Penwest Enters Into Collaboration Agreement With Edison Pharmaceuticals"
October 02, 2006, San Jose, California "Edison Pharma and Institute of Vision Enter into Collaboration"
August 01, 2006, Los Angeles and San Jose, California "CHDI and Edison Enter Collaborative Agreement"
April 04, 2006, San Jose, California "Edison Pharmaceuticals Announces FDA Grants EPI-A0001 Orphan Drug Designation for Inherited Mitochondrial Respiratory Chain Diseases"
March 20, 2006, San Jose, California "Edison Pharma Hires Director of Medicinal Chemistry"
March 16, 2006, San Jose, California, USA, Bologna, Italy, and New York, New York, USA "Edison Pharma, University of Bologna and Columbia University Medical Center Establish Mitochondrial Disease Partnership"
November 21, 2005, San Jose, California "Edison Pharmaceuticals Closes Series A Preferred Stock Offering"
Edison In The News:
July 21, 2008 "MitoAction Develops On-Line Resource for Mitochondrial Disease Care Providers" Download PDF (268.88 kb)
July 15, 2008 "First Human Dose of Promising New Friedreich's Ataxia Drug Initiated in Healthy Volunteers"
July 15, 2008 "Drug Trial begins targeting Mitochondrial Diseases"
July 14, 2008 "Penwest Begins Phase 1a Clinical Trial of A0001, a Compound For Treatment of Mitochondrial Diseases"
July 19, 2007 "Edison, Penwest Enter Deal on Orphan Neurological Disorders" Download PDF (108.75 kb)
November 05, 2006 "When Cells Stop Working"
July 14, 2006 "Edison accepted into NIH RAID Pilot Program"
December 12, 2005 "Private Money, Grants Funding Edison's Mitochondrial Pipeline" Download PDF (36.13 kb)